Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint (Q30620954)
scientific article
Language:
(P31) (Q13442814)
(P304) 13-22
(P407) (Q1860)
(P433) 1
(P478) 45
(P577) Monday, January 1, 2001
(P1433) (Q578004)
(P1476) "Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint" (language: en)
(P2093) G L Drusano
S L Preston
C Hardalo
R Hare
C Banfield
D Andes
O Vesga
W A Craig
(P2860) (Q31815905)
(Q33976467)
(Q54128912)
(Q41696128)
(Q42671287)
(Q35814807)
(Q35810298)
(Q39828366)
(Q36754206)
(Q52795932)
(Q54093848)
(Q54105200)
(Q44806786)
(Q71710583)
(Q71693373)
other details
description scientific article

External Links